Mitomycin C and its analog trigger cytotoxicity in MCF-7 and K562 cancer cells through the regulation of RAS and MAPK/ERK pathways.

MLA

Zacarias, Owen, et al. “Mitomycin C and Its Analog Trigger Cytotoxicity in MCF-7 and K562 Cancer Cells through the Regulation of RAS and MAPK/ERK Pathways.” Chemico-Biological Interactions, vol. 395, May 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.cbi.2024.111007.

APA

Zacarias, O., Clement, C. C., Cheng, S.-Y., Rosas, M., Gonzalez, C., Peter, M., Coopman, P., & Champeil, E. (2024). Mitomycin C and its analog trigger cytotoxicity in MCF-7 and K562 cancer cells through the regulation of RAS and MAPK/ERK pathways. Chemico-Biological Interactions, 395, N.PAG. https://doi.org/10.1016/j.cbi.2024.111007

Chicago

Zacarias, Owen, Cristina C. Clement, Shu-Yuan Cheng, Melissa Rosas, Christina Gonzalez, Marion Peter, Peter Coopman, and Elise Champeil. 2024. “Mitomycin C and Its Analog Trigger Cytotoxicity in MCF-7 and K562 Cancer Cells through the Regulation of RAS and MAPK/ERK Pathways.” Chemico-Biological Interactions 395 (May): N.PAG. doi:10.1016/j.cbi.2024.111007.